Search Results 631-640 of 15152 for alt

  1. Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation? - Mayo Clinic

    Elevation in AST, ALT, Bilirubin or alkaline phosphatase more than five times the upper limit of normal. Participating Mayo Clinic locations. Study statuses ...

  2. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    AST, ALT, and alkaline phosphatase ≤ 2.5 x ULN, with the following exceptions: Patients with documented liver metastases: AST and/or ALT ≤ 5 x ULN; ...

  3. A Study to Test the Addition of Nivolumab to Chemotherapy to Treat Soft Tissue Sarcoma - Mayo Clinic

    Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 2.5 x upper limit of normal (ULN). For patients with significant hepatic metastases, ALT and ...

  4. Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma - Mayo Clinic

    ANC ≥ 1500/mcL, AST and ALT < 2 x upper limit of normal (ULN), total bilirubin ≤ 3 mg/dL, creatinine clearance ≥ 50 mL/min, platelet count ≥ 100,000/mcL ...

  5. Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma - Mayo Clinic

    ... ALT < 5 times ULN for age). Shortening fraction of >= 27%; or; Ejection fraction of >= 50%. Patients must have a normal blood sugar level for age to ...

  6. A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma - Mayo Clinic

    If attributed to tumor involvement, AST and ALT <5×ULN. Subjects a history of hepatitis (Exclusion Criterion No. 11) must have ALT within the normal range.

  7. Liver transplant - Doctors & Departments - Mayo Clinic

    2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...

  8. A Study to Investigate the Effectiveness and Safety of Cannabidiol (GWP42003-P; CBD) as an Added Treatment for the Seizures Associated with Lennox-Gastaut Syndrome in Children and Adults - Mayo Clinic

    Alanine aminotransferase [ALT] >5 x upper limit of normal [ULN]; Or total bilirubin [TBL] >2 x ULN; Or the ALT or Aspartate aminotransferase (AST) >3 x ULN ...

  9. Liver transplant - Doctors & Departments - Mayo Clinic

    2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...

  10. Liver transplant - Doctors & Departments - Mayo Clinic

    2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...